Login to Your Account

Other News To Note

Wednesday, August 10, 2011
Gilead Sciences Inc., of Foster City, Calif., signed an agreement with Roche AG, of Basel, Switzerland, to purchase a clinical biologics manufacturing facility and process development assets in Oceanside, Calif., from Roche subsidiary Genentech Inc.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription